Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Firms / Ecphora Capital Management Company, LLC

Ecphora Capital Management Company, LLC

Seed fund manager · probableBaltimore, MDecphoracapital.comSEC exempt reporting adviser

Maryland's Premier Medtech Venture Capital Firm Ecphora’s vision is to establish Maryland as the global epicenter for medical commercialization, advancing groundbreaking innovations that transform medicine and healthcare worldwide Medical DeviceTech-enabled medical devices poised to revolutionize healthcare systems, processes, and patient treatment worldwide. BiotechPioneering novel therapies, precision medicine, gene editing, and regenerative medicine ventures to reshape

seed vehicles only

Importance
17
moderate
Active deployment
25
moderate
Emerging
0
low
Completeness
63
high
Freshness
100
high
Research priority
9
low
Identity and regulatory footprint
Headquarters
Baltimore, MDadviserinfo.sec.gov
Office address
8 MARKET PL, SUITE 400, Baltimore, MD, 21202adviserinfo.sec.gov
Business phone
(240) 547-9601adviserinfo.sec.gov
Website
https://www.ecphoracapital.com/
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
unknown
Latest Form ADV
Nov 4, 2024
Private funds reported
14 (14 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$9.3Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
business email
admin@ecphoracapital.comecphoracapital.compublished by the subject
business phone
(240) 547-9601adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
Sectors
ai, healthcare, biotech, medtech
Stages
not stated or not yet read
Geography
global, maryland, worldwide
Check size
not stated; DFX does not estimate checks from round sizes
Self-described
venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
14 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
Mi-Helper Spv, LPSPV or co-invest vehicle2024 form d first saleEarly deployment$884,818
Nov 4, 2024
1$1.0M
of $1.0M
Jul 11, 2024
Ecphora Capital Spv20, LPSPV or co-invest vehicle2024 form d first saleEarly deployment$360,000
Nov 4, 2024
2$360,000
of $600,000
Jul 9, 2024
Ecphora Capital Spv14, LPSPV or co-invest vehicle2023 form d first saleActive deployment$1.1M
Nov 4, 2024
2$565,417
of $565,417
Jul 8, 2024
Ecphora Capital Spv13, LPSPV or co-invest vehicle2023 form d first saleActive deployment$1.0M
Nov 4, 2024
1$1.1M
of $1.1M
Jul 8, 2024
Ecphora Capital Spv16, LPSPV or co-invest vehicle2023 form d first saleActive deployment$950,000
Nov 4, 2024
2$950,000
of $1.0M
Jul 8, 2024
Ecphora Capital Spv9, LPSPV or co-invest vehicle2023 form d first saleActive deployment$800,000
Nov 4, 2024
3$800,000
of $1.0M
Jul 3, 2024
Ecphora Capital Spv7, LPSPV or co-invest vehicle2023 form d first saleActive deployment$785,000
Nov 4, 2024
1$785,000
of $1.0M
Jul 3, 2024
Ecphora Capital Spv8, LPSPV or co-invest vehicle2023 form d first saleActive deployment$720,000
Nov 4, 2024
2$567,000
of $567,000
Jul 3, 2024
Ecphora Capital Spv17, LPSPV or co-invest vehicle2023 form d first saleActive deployment$389,900
Nov 4, 2024
2$389,900
of $600,000
Jul 8, 2024
Ecphora Capital Spv12, LPSPV or co-invest vehicle2023 form d first saleActive deployment$350,000
Nov 4, 2024
3$350,000
of $1.0M
Jul 8, 2024
Ecphora Capital Spv6, LPSPV or co-invest vehicle2023 form d first saleActive deployment$325,000
Nov 4, 2024
1$320,650
of $1.0M
Jul 3, 2024
Ecphora Capital Spv11, LPSPV or co-invest vehicle2023 form d first saleActive deployment$250,000
Nov 4, 2024
2$250,000
of $600,000
Jul 3, 2024
Ecphora Capital Spv5, LPSPV or co-invest vehicle2022 form d first saleActive deployment$1.2M
Nov 4, 2024
2$1.0M
of $1.0M
Jul 2, 2024
Ecphora Spv1, a Series of Ecphora Funds, LLPSPV or co-invest vehicle2022 form d first saleActive deployment$250,000
Nov 4, 2024
2$250,000
of $250,000
Jul 1, 2024
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
5 current, 0 departed
Deborah Hemingway
Managing Partner
Managing partner
FactVenture organization websites (about, team, portfolio, thesis, news pages)
Send Inquiry
Portfolio
Other
FactVenture organization websites (about, team, portfolio, thesis, news pages)
Deborah Hemingway
Manager · since Jun 1, 2022
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Jeremy Neilson
Managing Director, Head of Operations
Platform and operations
FactVenture organization websites (about, team, portfolio, thesis, news pages)
Sathya Janardhanan
Venture Partner,
Venture partner
FactVenture organization websites (about, team, portfolio, thesis, news pages)
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
15 dated events
  1. Sep 3, 2024
    Ecphora Capital Management Company, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)
    First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  2. Sep 3, 2024
    Ecphora Capital Spv8, LP first reported on Form ADV by Ecphora Capital Management Company, LLC (Venture Capital Fund), GAV $720,000
    Fund first reported on Form ADVFundsFactEcphora Capital Spv8, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  3. Sep 3, 2024
    Ecphora Capital Spv6, LP first reported on Form ADV by Ecphora Capital Management Company, LLC (Venture Capital Fund), GAV $325,000
    Fund first reported on Form ADVFundsFactEcphora Capital Spv6, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  4. Sep 3, 2024
    Ecphora Capital Spv9, LP first reported on Form ADV by Ecphora Capital Management Company, LLC (Venture Capital Fund), GAV $800,000
    Fund first reported on Form ADVFundsFactEcphora Capital Spv9, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  5. Sep 3, 2024
    Ecphora Capital Spv13, LP first reported on Form ADV by Ecphora Capital Management Company, LLC (Venture Capital Fund), GAV $1,000,000
    Fund first reported on Form ADVFundsFactEcphora Capital Spv13, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  6. Sep 3, 2024
    Ecphora Capital Spv5, LP first reported on Form ADV by Ecphora Capital Management Company, LLC (Venture Capital Fund), GAV $1,200,000
    Fund first reported on Form ADVFundsFactEcphora Capital Spv5, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  7. Sep 3, 2024
    Ecphora Spv1, a Series of Ecphora Funds, LLP first reported on Form ADV by Ecphora Capital Management Company, LLC (Venture Capital Fund), GAV $250,000
    Fund first reported on Form ADVFundsFactEcphora Spv1, a Series of Ecphora Funds, LLPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  8. Sep 3, 2024
    Ecphora Capital Spv14, LP first reported on Form ADV by Ecphora Capital Management Company, LLC (Venture Capital Fund), GAV $1,065,417
    Fund first reported on Form ADVFundsFactEcphora Capital Spv14, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  9. Sep 3, 2024
    Ecphora Capital Spv16, LP first reported on Form ADV by Ecphora Capital Management Company, LLC (Venture Capital Fund), GAV $950,000
    Fund first reported on Form ADVFundsFactEcphora Capital Spv16, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  10. Sep 3, 2024
    Ecphora Capital Spv17, LP first reported on Form ADV by Ecphora Capital Management Company, LLC (Venture Capital Fund), GAV $389,900
    Fund first reported on Form ADVFundsFactEcphora Capital Spv17, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  11. Sep 3, 2024
    Ecphora Capital Spv20, LP first reported on Form ADV by Ecphora Capital Management Company, LLC (Venture Capital Fund), GAV $360,000
    Fund first reported on Form ADVFundsFactEcphora Capital Spv20, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  12. Sep 3, 2024
    Ecphora Capital Spv12, LP first reported on Form ADV by Ecphora Capital Management Company, LLC (Venture Capital Fund), GAV $350,000
    Fund first reported on Form ADVFundsFactEcphora Capital Spv12, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  13. Sep 3, 2024
    Ecphora Capital Spv11, LP first reported on Form ADV by Ecphora Capital Management Company, LLC (Venture Capital Fund), GAV $250,000
    Fund first reported on Form ADVFundsFactEcphora Capital Spv11, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  14. Sep 3, 2024
    Ecphora Capital Spv7, LP first reported on Form ADV by Ecphora Capital Management Company, LLC (Venture Capital Fund), GAV $785,000
    Fund first reported on Form ADVFundsFactEcphora Capital Spv7, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  15. Sep 3, 2024
    Mi-Helper Spv, LP first reported on Form ADV by Ecphora Capital Management Company, LLC (Venture Capital Fund), GAV $884,818
    Fund first reported on Form ADVFundsFactMi-Helper Spv, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
  1. Sep 12, 2026
    Seed fund manager (probable, 80%, cls-1)
    seed vehicles only
Evidence
30 observations from 2 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC adviser typeexempt_reporting_adviserNov 4, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2024-09-03Nov 4, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2024-11-04Nov 4, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds1Nov 4, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone(240) 547-9601Nov 4, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Contact page urlhttps://ecphoracapital.com/contact-us/
“contact page linked from the home page”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionMaryland's Premier Medtech Venture Capital Firm Ecphora’s vision is to establish Maryland as the global epicenter for medical commercialization, advancing groundbreaking innovations that transform medicine and healthcare worldwide Medical DeviceTech-enabled medical devices poised to revolutionize healthcare systems, processes, and patient treatment worldwide. BiotechPioneering novel therapies, precision medicine, gene editing, and regenerative medicine ventures to reshape
“meta description”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionMaryland's Premier Medtech Venture Capital Firm Ecphora’s vision is to establish Maryland as the global epicenter for medical commercialization, advancing groundbreaking innovations that transform medicine and healthcare worldwide Medical DeviceTech-enabled medical devices poised to revolutionize healthcare systems, processes, and patient treatment worldwide. BiotechPioneering novel therapies, precision medicine, gene editing, and regenerative medicine ventures to reshape
“meta description”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersBaltimore, MDNov 4, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address8 MARKET PL, SUITE 400, Baltimore, MD, 21202Nov 4, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Self-described typeventure_capital
“Maryland's Premier Medtech Venture Capital Firm”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Self-described typeventure_capital
“Maryland's Premier Medtech Venture Capital Firm”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Legal formLimited Liability CompanyNov 4, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://ecphoracapital.com/portfolio/
“0 entries read”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Portfolio pagehttps://ecphoracapital.com/portfolio/
“0 entries read”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported14Nov 4, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$9.3MNov 4, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated geographyglobal,maryland,worldwide
“geography words on the home page”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated geographyglobal,maryland,worldwide
“geography words on the home page”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsai,healthcare,biotech,medtech
“sector words on the home page”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsai,healthcare,biotech,medtech
“sector words on the home page”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://ecphoracapital.com/team/
“4 name/title pairs read”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://ecphoracapital.com/team/
“4 name/title pairs read”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported14Nov 4, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Websitehttps://www.ecphoracapital.com/Nov 4, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleHome - Ecphora Capital
“title tag”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleHome - Ecphora Capital
“title tag”
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)